Empaglif Tablet 25 mg contains Empagliflozin 25 mg, an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor used to improve blood sugar control in adults with type 2 diabetes mellitus. In addition to lowering blood glucose levels, Empagliflozin offers significant cardiovascular and kidney protective benefits, making it an important treatment option for many patients with diabetes and related health conditions.

Empagliflozin works by helping the kidneys remove excess glucose from the body through urine. This insulin-independent mechanism helps reduce blood sugar levels while lowering the risk of hypoglycemia when used alone. It may also contribute to modest weight loss and a reduction in blood pressure.

Empaglif Tablet 25 mg is often prescribed alongside a healthy diet, regular exercise, and other antidiabetic medications when necessary. It is also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease and may be used in appropriate patients with heart failure or chronic kidney disease (CKD) as determined by a healthcare professional.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Empagliflozin 25 mg

How Empaglif Tablet Works

Empagliflozin belongs to the SGLT2 inhibitor class of medicines. It blocks the sodium-glucose co-transporter 2 (SGLT2) proteins in the kidneys, reducing the reabsorption of filtered glucose back into the bloodstream.

As a result, excess glucose is excreted in the urine, leading to lower blood sugar levels. This process also helps reduce the workload on the heart and kidneys, providing additional cardiovascular and renal protection in eligible patients.

Indications

Empaglif Tablet 25 mg is indicated for:

• Type 2 diabetes mellitus as an adjunct to diet and exercise
• Improvement of glycemic control in adults with type 2 diabetes
• Reduction of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
• Management of heart failure in appropriate patients
• Slowing the progression of chronic kidney disease (CKD) in eligible patients, as advised by a physician

Note: Empaglif Tablet is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Benefits of Empaglif Tablet

• Effectively lowers blood glucose levels
• Helps reduce HbA1c in patients with type 2 diabetes
• Lowers the risk of cardiovascular death in eligible patients
• Supports heart failure management
• Helps protect kidney function in appropriate patients
• May promote modest weight loss
• May help reduce blood pressure
• Convenient once-daily oral dosing

Dosage and Administration

Take Empaglif Tablet exactly as prescribed by your healthcare provider.

• Swallow the tablet whole with a glass of water.
• It may be taken with or without food.
• Take it once daily at the same time each day.
• Stay adequately hydrated during treatment.
• Continue following your recommended diet, exercise plan, and blood glucose monitoring schedule.

Do not stop taking the medicine without consulting your healthcare provider.

Possible Side Effects

Like all medicines, Empaglif Tablet may cause side effects, although not everyone experiences them.

Common side effects include:

• Increased urination
• Urinary tract infection
• Genital yeast infections
• Increased thirst
• Mild dehydration
• Dizziness

Serious but less common side effects include:

• Diabetic ketoacidosis
• Severe urinary tract infections
• Kidney function impairment
• Low blood pressure due to dehydration
• Severe allergic reactions

Seek immediate medical attention if you experience symptoms such as severe abdominal pain, persistent vomiting, difficulty breathing, confusion, or signs of a serious infection.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

Before taking Empaglif Tablet, inform your healthcare provider if you:

• Have kidney disease or reduced kidney function
• Have liver disease
• Have low blood pressure or dehydration
• Have a history of recurrent urinary tract or genital infections
• Have a history of diabetic ketoacidosis
• Are pregnant, planning to become pregnant, or breastfeeding
• Are taking diuretics, insulin, or other antidiabetic medications

Regular monitoring of blood glucose, kidney function, blood pressure, and overall health is recommended during treatment.

Storage

• Store below 30°C in a cool and dry place.
• Protect from moisture and direct sunlight.
• Keep the tablets in their original packaging.
• Keep out of the reach of children.
• Do not use after the expiry date printed on the package.